Y Li1, C D Russell, J Palmer-Lawrence, E V Dubovsky. 1. Department of Nuclear Medicine, First Hospital, Sun Yet-Sen University of Medical Sciences, Guangzehou, Guangdong, China.
Abstract
UNLABELLED: When imaging renal transplants with tubular agents, such as mercaptoacetyltriglycine, marked parenchymal retention is a hallmark of acute rejection (AR) or acute tubular necrosis (ATN). (AR can be distinguished from ATN by the time course on serial studies.) The quantitative relationship of retention to uptake can be measured by dividing the background-corrected renal activity at 20 min by that at 3 min. METHODS: The diagnostic value of this ratio (R20/3) was tested in a series of 555 renograms. Because patients with mild disease have minimal abnormalities, the patients were ranked by their estimated severity of disease (1-4 for abnormal and 0 for normal). RESULTS: R20/3 was found to correlate strongly with severity of ATN (Spearman's rho = 0.879, p < 0.001, n = 168) and also with severity of AR (rho = 0.888, p < 0.001, n = 267). There were two (3%) false-positive results in 64 normal patients. CONCLUSION: If 0.8 is taken as the upper limit of normal for R20/3, then among patients with disease severity 3 or 4, there were no false-negative findings in 104 patients with ATN or in 203 patients with AR. R20/3, despite its simplicity, is an effective diagnostic parameter.
UNLABELLED: When imaging renal transplants with tubular agents, such as mercaptoacetyltriglycine, marked parenchymal retention is a hallmark of acute rejection (AR) or acute tubular necrosis (ATN). (AR can be distinguished from ATN by the time course on serial studies.) The quantitative relationship of retention to uptake can be measured by dividing the background-corrected renal activity at 20 min by that at 3 min. METHODS: The diagnostic value of this ratio (R20/3) was tested in a series of 555 renograms. Because patients with mild disease have minimal abnormalities, the patients were ranked by their estimated severity of disease (1-4 for abnormal and 0 for normal). RESULTS:R20/3 was found to correlate strongly with severity of ATN (Spearman's rho = 0.879, p < 0.001, n = 168) and also with severity of AR (rho = 0.888, p < 0.001, n = 267). There were two (3%) false-positive results in 64 normal patients. CONCLUSION: If 0.8 is taken as the upper limit of normal for R20/3, then among patients with disease severity 3 or 4, there were no false-negative findings in 104 patients with ATN or in 203 patients with AR. R20/3, despite its simplicity, is an effective diagnostic parameter.
Authors: M Donald Blaufox; Diego De Palma; Andrew Taylor; Zsolt Szabo; Alain Prigent; Martin Samal; Yi Li; Andrea Santos; Giorgio Testanera; Mark Tulchinsky Journal: Eur J Nucl Med Mol Imaging Date: 2018-08-30 Impact factor: 9.236
Authors: Sandeep K Gupta; Guy Lewis; Kerry M Rogers; John Attia; Kirk Rostron; Leanne O'Neill; Annah Skillen; Suresh Viswanathan Journal: Am J Nucl Med Mol Imaging Date: 2014-04-25
Authors: Stan Benjamens; Robert A Pol; Lioe-Fee de Geus-Oei; Aiko P J de Vries; Andor W J M Glaudemans; Stefan P Berger; Riemer H J A Slart Journal: PLoS One Date: 2018-03-21 Impact factor: 3.240